RT Journal Article
SR Electronic
T1 Aromatase inhibitors in breast cancer: Current and evolving roles
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 561
OP 567
VO 69
IS 7
A1 Hill, John
A1 Moore, Halle
YR 2002
UL http://www.ccjm.org/content/69/7/561.abstract
AB The aromatase inhibitors are established first-line drugs for treating metastatic breast cancer in postmenopausal women, and are gaining acceptance as adjuvant treatment as well.